Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

URGNURGN
Showing 6 of 16 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in UROGEN PHARMA LTD

Point72 Asset Management, L.P. holds 1.5M shares of URGN (UROGEN PHARMA LTD), worth $56.1M as of 2026-Q2. This is a new position. URGN represents 0.1% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$56.1M

Current Shares

1.5M

Total Value Change

+$37M

Total Shares Change

+18,903

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.5M
-
$56.1M0.1%$36.80
41
2025-Q3
Exited
0
-100.0%
$00.0%$19.14
0
2025-Q2
Decreased
168,779
-28.5%
$2.3M0.0%$13.49
0
2025-Q1
Decreased
236,006
-25.6%
$2.6M0.0%$11.20
0
2024-Q4
Decreased
317,114
-79.0%
$3.4M0.0%$10.52
0
2024-Q3
Decreased
1.5M
-38.5%
$19.1M0.0%$12.90
0

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used